Vaccinex, Inc.
VCNX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001205922
No open-market purchases or sales by Vaccinex, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Vaccinex, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +3 vs. Q3 2022
- Shares held
- 4.69M
- +74.5K (+1.6%) vs. Q3 2022
- Total value
- $3.12M
- +$833.5K (+36.5%) vs. Q3 2022
- New holders
- 5
- 4 more added
- Sold out
- 2
- 8 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VCNX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $45 |
| Q3 2024 | 12 | $1.14M |
| Q2 2024 | 11 | $1.81M |
| Q1 2024 | 12 | $2.41M |
| Q4 2023 | 18 | $1.07M |
| Q3 2023 | 19 | $2.92M |
| Q2 2023 | 23 | $994.8K |
| Q1 2023 | 24 | $1.10M |
| Q4 2022 | 25 | $3.12M |
| Q3 2022 | 22 | $2.28M |
| Q2 2022 | 27 | $5.03M |
| Q1 2022 | 25 | $5.49M |
| Q4 2021 | 21 | $1.68M |
| Q3 2021 | 23 | $3.36M |
| Q2 2021 | 28 | $4.54M |
| Q1 2021 | 33 | $2.79M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Vaccinex, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AIGH Capital Management LLC | 2,451,801 | $1.66M | 0.55% | +370,000+17.8% | Added |
| Vanguard Group Inc | 732,859 | $472.3K | 0.00% | +694+0.1% | Added |
| Worth Venture Partners, LLC | 507,795 | $334.6K | 0.20% | 00.0% | Unchanged |
| Telemetry Investments, L.L.C. | 416,000 | $268.0K | 0.63% | −74,000−15.1% | Reduced |
| Geode Capital Management, LLC | 250,186 | $164.0K | 0.00% | −694−0.3% | Reduced |
| State Street Corp | 71,400 | $47.1K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 65,174 | $42.0K | 0.00% | −1,370−2.1% | Reduced |
| BlackRock Inc. | 50,589 | $32.6K | 0.00% | +1,072+2.2% | Added |
| Millennium Management LLC | 37,964 | $25.0K | 0.00% | −32,847−46.4% | Reduced |
| Northern Trust Corp | 23,369 | $15.1K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 20,971 | $13.5K | 0.00% | 00.0% | Unchanged |
| Creative Planning | 11,000 | $7.09K | 0.00% | 00.0% | Unchanged |
| Moors & Cabot, Inc. | 10,000 | $6.45K | 0.00% | 00.0% | Unchanged |
| HNP Capital LLC | 10,000 | $6.45K | 0.00% | 00.0% | Unchanged |
| Vectors Research Management, LLC | 10,000 | $6.00K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 7,588 | $5.00K | 0.00% | −92,680−92.4% | Reduced |
| Royal Bank of Canada | 5,153 | $3.00K | 0.00% | −266−4.9% | Reduced |
| Advisor Group Holdings, Inc. | 3,500 | $2.00K | 0.00% | −100−2.8% | Reduced |
| UBS Group AG | 2,151 | $1.38K | 0.00% | +2,151 | New |
| Morgan Stanley | 300 | $193 | 0.00% | −64−17.6% | Reduced |
| Wells Fargo & Company | 189 | $122 | 0.00% | +5+2.7% | Added |
| Cornerstone Planning Group LLC | 200 | $122 | 0.00% | +200 | New |
| Money Concepts Capital Corp | 110 | $71 | 0.00% | +110 | New |
| Bank of America Corp | 54 | $34 | 0.00% | +54 | New |
| CWM, LLC | 300 | $0 | 0.00% | +300 | New |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −87,700−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −10,370−100.0% | Sold out |